Companies
- Companies
- Company details
Adelaide Research and Innovation Pty Ltd
Out-licensing
Asparagine Hydroxylation of Human HIF and Hypoxia Responses: Elucidation of Agonists or Antagonists for use in Ischaemic Heart Disease, Wound Healing and Cancer More
Biotin Protein Ligase: A Target for the Development of Selective Anti-infective Agents More
Development of a Monoclonal Antibody to the IGF Receptor: Potential Cancer Applications More
Development of a Novel Treatment for Ischaemic Stroke: Reduction of Cerebral Oedema More
Method of ES Cell Isolation: Development of the use of Stem Cells as a Platform Technology More
MRI-Based Analysis of Blood Flow: Non-Invasive Diagnostic Software for Heart Abnormalities More
Novel Target for Drugs that Manipulate Ovulation for Contraception, Infertility and Maintenance of Ovarian Reserve More
Phase II Clinical Development of a Melanoma Vaccine: Treatment of Stage IV Melanoma More
Towards the Development of a Vaccination for STEC Cytotoxin: Elucidation of a New Class of Bacterial AB5 Toxins More
Towards the Development of Novel Cancer Therapeutics: Potential use of Novel Variants of IGF Binding Protein 2 More
Treatment and Diagnosis of an Infertility Condition by Measuring or Inhibiting Interferon-Gamma More
Related Reports
Market Research Reports provided by reports.iptechex.com
Oct 2010 - 22 pages - $99
Feb 2011 - 11 pages - $99
Feb 2011 - 11 pages - $99
Feb 2011 - 14 pages - $99
Oct 2010 - 11 pages - $99
Feb 2011 - 10 pages - $99
Feb 2011 - 13 pages - $99
Jan 2011 - 14 pages - $99
Dec 2010 - 15 pages - $99
Nov 2010 - 13 pages - $99
Contact details
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us